Results for tag: "Malakoplakia"

Malakoplakia is a rare disorder of the urinary tract and kidneys that is characterized by the formation of granulomatous lesions. It is most commonly seen in adults, and is caused by an abnormal response to bacterial infection. Treatment typically involves antibiotics, and in some cases, surgery. The Malakoplakia market within the context of Urology and Nephrology is a niche market that is focused on providing treatments for this rare disorder. The market is composed of pharmaceutical companies, medical device manufacturers, and healthcare providers. These companies are focused on developing treatments and therapies that can help patients manage their symptoms and improve their quality of life. Some companies in the Malakoplakia market include Pfizer, Merck, AstraZeneca, Novartis, and Johnson & Johnson. Show Less Read more